kneat.com has signed a five-year master service agreement with another one of the world’s largest pharmaceutical companies, to digitalize key validation processes across its manufacturing sites. Implementation has begun with an expected phase one Go Live on the lead site in Q1 2020. This agreement allows the customer and its affiliates, with more than 60,000 employees worldwide, to expand Kneat across all its global sites, representing a significant opportunity for growth and expansion of Kneat's platform.
"We are excited to be the chosen solution by this global leader and we look forward to working closely with their global teams to digitalize all aspects of their validation processes", said Eddie Ryan, Chief Executive Officer of Kneat. "This company is a standard setter within Life Sciences and we are very proud to add them to our growing customer list of tier one global healthcare companies."